This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The firm fixed price delivery order is for the supply of Bupropion Hydrochloride Extended-Release Tablets, a generic prescription medication, with a ceiling value of $2,344.34 and a period of performance through March 28, 2024.
Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This latest award is issued under that IDC. No set-aside designation was used for this contract.
Generated 6/26/24, 9:52 AM